| tenofovir disoproxil fumarate / Generic mfg. |
NCT00324688: Safety Study of Once a Day ART and Opiate Substitute. |
|
|
| Completed | 4 | 60 | Europe | Viread | Gilead Sciences | HIV Infections | | 06/06 | | |
| Terminated | 4 | 24 | Europe | Trizivir (AZT+3HT+Abacavir) twice daily, Viread (300 mg Tenofovir disoproxil fumarate) once daily | Germans Trias i Pujol Hospital, Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | HIV Infections | 06/07 | 06/07 | | |
| Completed | 4 | 8 | Europe | Tenofovir Disoproxil Fumarate, Tenofovir DF placebo | Gilead Sciences | HIV Infections | 11/07 | 12/07 | | |
ACLF, NCT01074645: Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure |
|
|
| Completed | 4 | 27 | RoW | Tenofovir disoproxil fumarate (TDF) | Govind Ballabh Pant Hospital | Acute on Chronic Liver Failure, Hepatitis B | 06/09 | 10/09 | | |
NCT00662545: Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection |
|
|
| Completed | 4 | 10 | US | Entecavir with continued standard of care antiretroviral therapy, Baraclude, Tenofovir, Truvada, Viread, 3TC, FTC, Epivir, Emtriva, continued standard of care with tenofovir in addition to emtricitabine or lamivudine, Tenofovir, Truvada, Viread, 3TC, FTC, Epivir, Emtriva | University of California, San Francisco, Bristol-Myers Squibb | HIV Infections, Hepatitis B | 02/10 | 05/10 | | |
NCT00552240: Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) |
|
|
| Completed | 4 | 154 | US | tenofovir DF 300 mg QD, emtricitabine 200 mg QD, Nevirapine 200 mg BID, Atazanavir 300 mg, Ritonavir 100 mg | Boehringer Ingelheim | HIV Infections | 03/10 | | | |
NCT00736190: A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection |
|
|
| Completed | 4 | 90 | US | Tenofovir disoproxil fumarate, Viread | Gilead Sciences | Chronic Hepatitis B | 07/10 | 07/10 | | |
| Completed | 4 | 40 | Europe | Tenofovir disoproxil fumarate, Abacavir | Aarhus University Hospital | HIV Infections | 08/10 | 08/10 | | |
NCT00651209 / 2007-004845-14: A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) |
|
|
| Completed | 4 | 105 | Europe, RoW | Tenofovir, Sebivo, Tyzeka, Viread | Novartis Pharmaceuticals | Hepatitis B, Chronic | 12/11 | | | |
NCT01340950: Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China |
|
|
| Completed | 4 | 250 | RoW | zidovudine-lamivudine-nevirapine, Retrovir, Epivir, Viramune, tenofovir-lamivudine-efavirenz, Viread, Epivir, Sustiva | University of California, San Diego, National Institute of Mental Health (NIMH), National Center for AIDS/STD Control and Prevention, China CDC, Beijing YouAn Hospital, Beijing Ditan Hospital, Peking University | HIV Infections, Central Nervous System Diseases, Dementia | 07/14 | 07/15 | | |
NCT01277601 / 2010-024586-45: Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B |
|
|
| Completed | 4 | 751 | US, Canada, Europe, RoW | TDF, Viread®, Peg-IFN, Pegasys® | Gilead Sciences | Chronic Hepatitis B | 08/14 | 07/15 | | |
| Completed | 4 | 22 | Europe | HAART, Viread, Epivir, Kaletra, HAART + Immunotherapy, Cyclosporine A, GM-CSF, Peg-IFN, Interleukin-2 | Juan A. Arnaiz | HIV | 11/14 | 11/14 | | |
NCT01448616: Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding |
|
|
| Completed | 4 | 73 | US | TDF, Tenofovir disoproxil fumarate (TDF) oral tablets, Placebo Vaginal Gel, Placebo gel, Vaginal TFV Gel, Tenofovir 1% Vaginal Gel, Placebo Tablets, Oral placebo | University of Washington, CONRAD, Gilead Sciences | Herpes Simplex Type II | 06/15 | 06/15 | | |
NCT01711567: Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir |
|
|
| Completed | 4 | 60 | RoW | tenofovir, tenofovir (viread), entecavir, entecavir(baraclude) 0.5 mg qd | Korea University, Gilead Sciences | Chronic Hepatitis B | 12/15 | 11/16 | | |
| Completed | 4 | 241 | Europe, RoW | telbivudine, LDT600, tenofovir disoproxil fumarate | Novartis Pharmaceuticals | Chronic Hepatitis B | 12/15 | 12/15 | | |
NCT01732367: TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA |
|
|
| Completed | 4 | 171 | RoW | Lamivudine plus adefovir, Zeffix, Hepsera, Tenofovir, Viread | Keimyung University Dongsan Medical Center, Kyungpook National University Hospital, Daegu Catholic University Medical Center, DongGuk University, Pusan National University Hospital, Yeungnam University Hospital | Chronic Hepatitis B | 03/16 | 04/16 | | |
| Completed | 4 | 43 | Europe | TDF, Viread®, Stop TDF | Gilead Sciences | Chronic Hepatitis B | 07/16 | 08/16 | | |
| Completed | 4 | 102 | RoW | Tenofovir, Viread, Entecavir, Baraclude | Asan Medical Center, Samsung Medical Center, Konkuk University Medical Center, Korea University Guro Hospital, Seoul National University Hospital | Chronic Viral Hepatitis B Without Delta-agent | 09/17 | 09/17 | | |
| Completed | 4 | 88 | RoW | Tenofovir, Viread, Entecavir, Baraclude | Asan Medical Center, Samsung Medical Center, Konkuk University Medical Center, Korea University Guro Hospital, Seoul National University Hospital | Chronic Viral Hepatitis B Without Delta-agent | 03/18 | 03/18 | | |
| Completed | 4 | 160 | RoW | tenofovir disoproxil fumarate 300mg per day, Viread® (Gilead Sciences Inc), Placebo | E-DA Hospital, Gilead Sciences, Taipei Institute of Pathology | Chronic Hepatitis B | 11/18 | 12/18 | | |
